Page 17 - American College of Allergy, Asthma and Immunology 2024 Annual Scientific Meeting Registration Program

Friday General Sessions
6:45 – 7:45 am
Non-CME Corporate Forums
8:00 – 9:30 am
Symposium
Why Am I So Itchy?
Moderators: Sandra M. Gawchik, DO, FACAAI; and Jaspreet Benipal, DO
Pruritus is a common complaint of patients seen by allergists. Chronic itch is frequently difficult to treat. This session offers a comprehensive overview of the neural mechanics of itch. Systemic and cutaneous manifestation of itch along with the latest approaches to diagnosis, classification, and treatment of patients with various degrees of pruritus will be discussed.
Track: Dermatology
Welcome and Introductions
Sandra M. Gawchik, DO, FACAAI; and Jaspreet Benipal, DO
The Neural Mechanism of Itch: Emerging Concepts
Gil Yosipovitch, MD
Cutaneous and Systemic Manifestations of Itch
Aaron M. Ver Heul, MD, PhD
Approach to Management and Treatment of Patients With Chronic Itch
Luz S. Fonacier, MD, FACAAI
Questions & Discussion
8:00 – 9:30 am
Symposium
Epinephrine Uncertainty
Moderators: Joseph P. Forester, DO, FACAAI; and Sara Anvari, MD, MSc, FACAAI
Epinephrine is the first line treatment for anaphylaxis. However, there continues to be confusion on when to administer epinephrine and concerns regarding the use of epinephrine. This session will highlight what constitutes anaphylaxis and when to administer epinephrine, novel delivery routes of epinephrine, and if patients need to be monitored in a healthcare setting after epinephrine use.
Track: Rhinitis/Sinusitis/Ocular and Anaphylaxis
Welcome and Introductions
Joseph P. Forester, DO, FACAAI; and Sara Anvari, MD, MSc, FACAAI
What the Heck Is Anaphylaxis?
Julia E. Upton, MD
Epinephrine in the Community: What’s Best Practice?
Marcus S. Shaker, MD, FACAAI
But I’m Scared of Needles! Novel Routes of Epinephrine Administration
David B. K. Golden, MD, FACAAI
Questions & Discussion
Continues on next page
Register online at: annualmeeting.acaai.org 17 Table of Contents